Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-α converting enzyme (TACE) inhibitors

被引：26
|
作者：
Park, Kaapjoo [1 ]
Gopalsamy, Ariamala [1 ]
Aplasca, Alexis [1 ]
Ellingboe, John W. [1 ]
Xu, Weixin [2 ]
Zhang, Yuhua [3 ]
Levin, Jeremy I. [1 ]
机构：
[1] Wyeth Res, Chem Sci, Pearl River, NY 10965 USA
[2] Wyeth Res, Chem Sci, Cambridge, MA 02140 USA
[3] Wyeth Res, Inflammat, Cambridge, MA 02140 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2009年 / 17卷 / 11期
关键词：
Non-hydroxamate; TNF-alpha converting enzyme (TACE) inhibitor; Tryptophan sulfonamide derivatives; Martix metalloprotease (MMP); TUMOR-NECROSIS-FACTOR; MATRIX-METALLOPROTEINASE INHIBITORS; STRUCTURE-BASED DESIGN; RHEUMATOID-ARTHRITIS; SELECTIVE INHIBITORS; THERAPEUTIC APPLICATION; PART; IDENTIFICATION; DISCOVERY; POCKET;
D O I：
10.1016/j.bmc.2009.04.033
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A novel series of non-hydroxamate tryptophan sulfonamide derivatives containing a butynyloxy P1' moiety was identified as inhibitors of TNF-alpha converting enzyme (TACE). The structure-activity relationship of the series was examined via substitution on the tryptophan indole ring. Of the compounds investigated, 2-(4-(but-2-ynyloxy) phenylsulfonamido)-3-(1-(4-methoxybenzyl)-1H-indol-3-yl) propanoic acid (12p) has the best in vitro potency against isolated TACE enzyme with an IC50 of 80 nM. Compound 12p also shows good selectivity over MMP-1, -13, -14. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3857 / 3865
页数：9
相关论文
共 50 条
  • [21] Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity
    Lee, Eun-Jung
    Moon, Pyong-Gon
    Baek, Moon-Chang
    Kim, Hee-Sun
    BIOMOLECULES & THERAPEUTICS, 2014, 22 (05) : 414 - 419
  • [22] Molecularly targeted approach to cancer therapy: Design, synthesis and biological activity of non-hydroxamate histone deacetylase inhibitors
    Suzuki, T
    Nakagawa, H
    Miyata, N
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2005, 63 (10) : 1004 - 1015
  • [23] Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-α converting enzyme inhibitors
    Letavic, MA
    Barberia, JT
    Carty, TJ
    Hardink, JR
    Liras, J
    Lopresti-Morrow, LL
    Mitchell, PG
    Noe, MC
    Reeves, LM
    Snow, SL
    Stam, EJ
    Sweeney, FJ
    Vaughn, ML
    Yu, CH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) : 3243 - 3246
  • [24] Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors
    Gilmore, JL
    King, BW
    Harris, C
    Maduskuie, TP
    Mercer, SE
    Liu, RQ
    Covington, MB
    Qian, MX
    Ribadeneria, MD
    Vaddi, KG
    Trzaskos, JM
    Newton, RC
    Decicco, CP
    Duan, JJW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2667 - U2668
  • [25] Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1′, a series of selective TNF-α converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-α release
    Xue, CB
    He, XH
    Corbett, RL
    Roderick, J
    Wasserman, ZR
    Liu, RQ
    Jaffee, BD
    Covington, MB
    Qian, MX
    Trzaskos, JM
    Newton, RC
    Magolda, RL
    Wexler, RR
    Decicco, CP
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (21) : 3351 - 3354
  • [26] Novel benzimidazole-linked (thio)barbiturates as non-hydroxamate HDAC6 inhibitors targeting leukemia: Design, synthesis, and structure-activity relationship
    Mansour, Reda El-Sayed
    Abdulwahab, Hanan Gaber
    El-Sehrawi, Hend M.
    ARCHIV DER PHARMAZIE, 2023, 356 (06)
  • [27] Synthesis and activity of novel phosphinic acid inhibitors of endothelin converting enzyme.
    Stamford, AW
    McKittrick, BA
    Chackalamannil, S
    Chung, S
    Weng, XY
    Tsai, HG
    Wang, YG
    Ma, K
    Tong, MK
    Emeigh, J
    Czarniecki, M
    Fawzi, AB
    Cleven, RM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 18 - MEDI
  • [28] CoMFA and CoMSIA Analyses of Highly Selective Pipecolic Acid Based TNF-α Converting Enzyme (TACE) Inhibitors Using Docked Conformations for Molecular Alignment
    Bahia, Malkeet Singh
    Chand, Sukhvir
    Gunda, Shravan Kumar
    Gade, Shwetha Reddy
    Mahmood, Saikh
    Silakari, Om
    LETTERS IN DRUG DESIGN & DISCOVERY, 2011, 8 (05) : 430 - 439
  • [29] Structure based optimization of chromen-based TNF-α converting enzyme (TACE) inhibitors on S1′ pocket and their quantitative structure-activity relationship (QSAR) study
    Yang, Jee Sun
    Chun, Kwangwoo
    Park, Jung Eun
    Cho, Misun
    Seo, Jeongjea
    Song, Doona
    Yoon, Hongchul
    Park, Chun-Ho
    Joe, Bo-Young
    Choi, Jong-Hee
    Kim, Myung-Hwa
    Han, Gyoonhee
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (24) : 8618 - 8629
  • [30] Prediction of novel and selective TNF-alpha converting enzyme (TACE) inhibitors and characterization of correlative molecular descriptors by machine learning approaches
    Cong, Yong
    Yang, Xue-gang
    Lv, Wei
    Xue, Ying
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2009, 28 (03): : 236 - 244
12345